Compare ACGC & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACGC | VRXA |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 263.0M |
| IPO Year | 2026 | 2025 |
| Metric | ACGC | VRXA |
|---|---|---|
| Price | $10.00 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 68.5K | ★ 154.8K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.92 | $1.70 |
| 52 Week High | $10.00 | $4.50 |
| Indicator | ACGC | VRXA |
|---|---|---|
| Relative Strength Index (RSI) | 66.86 | 42.65 |
| Support Level | $9.93 | $1.74 |
| Resistance Level | N/A | $2.00 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 100.00 | 86.00 |
ACP Holdings Acquisition Corp is a blank check company.
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.